Financial Performance - The company's revenue for the year ended December 31, 2022, was approximately HKD 144.6 million, a decrease of about 10.1% compared to HKD 160.9 million in 2021[22]. - Gross profit for the same period was HKD 113.9 million, resulting in a gross margin of 78.8%, up from 65.1% in the previous year[22]. - The company reported a profit attributable to shareholders of HKD 9.6 million, a significant recovery from a loss of HKD 60.8 million in 2021[22]. - The group's revenue for the year was approximately HKD 144.6 million, a decrease of about 10.1% compared to approximately HKD 160.9 million in the previous year, primarily due to a decline in footwear business revenue[36]. - Footwear business revenue for the year was approximately HKD 141.4 million, down about 7.5% from approximately HKD 152.9 million in the previous year, attributed to a significant decline in foot traffic and consumer spending due to tightened pandemic measures[30]. - The health supplement segment generated revenue of approximately HKD 200,000, a decrease of about 88.2% from approximately HKD 1.7 million in the previous year, mainly due to ongoing COVID-19 outbreaks in Australia[40]. - Online medical services recorded revenue of approximately HKD 400,000, down from approximately HKD 800,000 in the previous year, reflecting the continued low revenue impact from the pandemic[32]. - The financial services segment's revenue was approximately HKD 2.5 million, a decrease of about 55.4% from approximately HKD 5.6 million in the previous year, primarily due to reduced investment management and advisory service income[39]. - The total comprehensive loss for the year was HKD 3,101,000, down from HKD 6,743,000 in 2021, indicating a 54% reduction in losses[178]. Liquidity and Financial Health - The current ratio remains at 0.7, indicating a stable liquidity position[6]. - The total liabilities to equity ratio improved to 102.6% from 311.8% in the previous year, reflecting better financial health[6]. - The asset-to-equity ratio improved to approximately 102.6% from about 311.8% in the previous year, mainly due to a decrease in other borrowings and bank loans[49]. - As of December 31, 2022, the group's cash and bank balances were approximately HKD 33.6 million, an increase of about 25.8% from approximately HKD 26.7 million at the end of the previous year[47]. - As of December 31, 2022, the company had a current liability exceeding its current assets by approximately HKD 48,415,000, raising significant doubts about its ability to continue as a going concern[73]. - The company reported a net cash outflow from operating activities of HKD 2,781,000 in 2022, compared to HKD 3,051,000 in 2021, showing an improvement of 8.9%[179]. - The company reported a net cash outflow of HKD 3,222,000 in 2022, slightly higher than HKD 3,034,000 in 2021[179]. Business Strategy and Market Expansion - The company plans to expand its market presence in Singapore and Australia while implementing cost control measures[10][13]. - The company aims to consolidate its business segments and seek strategic partnerships in the health industry to create sustainable value for shareholders[18]. - The company plans to allocate 30% of its funds, approximately HKD 22,349,100, to enhance the supply chain and develop new products in the Australian health supplement sector[69]. - TATA Health will continue to seek strategic partnerships in the health industry to build a healthy business ecosystem[87]. - The company aims to improve its one-stop internet hospital platform, focusing on customer service support and product development[69]. - The online healthcare service business is in the final stages of its initial phase, with plans to strengthen marketing efforts and expand sales performance after establishing a one-stop internet medical platform[60]. Employee and Training Initiatives - The company employed 156 staff members as of December 31, 2022, down from 185 in the previous year, and conducted various training activities to improve service quality[70]. - The total training hours during the reporting period amounted to approximately 1,399 hours, a significant increase from 623 hours in the previous year[152]. - The average training hours per employee are 14.0 hours for females and 25.0 hours for males, indicating a disparity in training engagement[154]. - The company invests in employee development and training, recognizing human capital as a critical component of its ongoing success[161]. - Employee turnover rate by gender shows 19% for males and 81% for females, with a total turnover rate of 22% in China, 3% in Australia, and 75% in Hong Kong[150]. Environmental, Social, and Governance (ESG) Efforts - TATA Health aims to enhance shareholder, customer, and community value through high-quality products and services while focusing on sustainable development[75]. - The group is committed to maintaining good corporate governance standards and reducing greenhouse gas emissions, energy consumption, and protecting natural resources[75]. - The company has identified key environmental, social, and governance (ESG) issues through stakeholder engagement and materiality assessments[84]. - The company has established an ESG task force to enhance employee awareness of environmental protection and social responsibility[78]. - The company monitors various key performance indicators related to ESG matters to assess the effectiveness of its policies and management systems[78]. - The company has implemented various environmental measures in its workplaces, including the use of LED lighting to reduce energy consumption[111]. - The company is gradually adopting electronic work platforms to move towards a paperless workplace[108]. - The company actively encourages employees to reduce printing and use double-sided printing for internal documents[108]. - The company has reduced greenhouse gas emissions intensity by approximately 34.61% during the reporting period[109]. - The company achieved a reduction in electricity consumption to 244,320 kWh in 2022 from 333,955 kWh in 2021, marking a decrease of about 26.8%[139]. - The company maintained a relatively low water consumption during the reporting period, with total water usage remaining stable at approximately 0.1 tons, consistent with the previous year[143]. - Over 90% of the leather used in the company's shoe products is sourced from suppliers certified by the Leather Working Group, ensuring environmental protection standards[144]. - The company encourages the use of eco-friendly materials, with 95% of the packaging for its Clarks brand shoes made from environmentally friendly materials[142]. - The company aims to continuously monitor and reduce non-hazardous waste generation annually[134]. - The company has not encountered any significant environmental law violations during the reporting period in Hong Kong and Australia[134]. Corporate Governance and Compliance - The company is committed to adhering to labor standards, prohibiting child and forced labor, and regularly reviewing employee data to ensure compliance[154]. - The company has implemented internal guidelines and reporting systems regarding occupational health and safety, ensuring a high standard of hygiene and safety in retail environments[151]. - There were no product recalls due to safety and health reasons during the reporting period, and the company received zero complaints related to products or services[157]. - The company has not reported any serious or fatal workplace injuries over the past three years, indicating a strong health and safety record[166]. - The company has developed emergency plans to address extreme weather conditions, ensuring continuity of operations during adverse events[160]. - The company has no significant related party transactions that require disclosure under the listing rules for the year[194]. - There were no major post-balance sheet events affecting the group since the end of the financial year[200].
TATA健康(01255) - 2022 - 年度财报